Leadership team —Meet the Fullscript executives
At the forefront of our mission
The Fullscript leadership team leads our organization in making integrative medicine accessible to all. Learn more about Fullscript’s mission as we empower practitioners and patients with everything they need to promote lifelong wellness.
Our executive team
Learn about Fullscript’s leaders and their roles in driving innovation.
Our board members
Learn about Fullscript’s board members and their previous ventures.
Get to know our mission
Chief Executive Officer
As Chief Executive Officer, Kyle Braatz leads Fullscript with a focus on growth through technology and innovation. Kyle co-founded Fullscript in 2011 and successfully merged with Natural Partners in 2018.
He continues to lead the organization through massive growth, earning Fullscript the number two spot on Canadian Business’s 2020 fastest-growing companies in Canada. Kyle has been awarded Canada’s Top 40 under 40, Ottawa’s top 40 under 40, and both the Young Achiever Award and the Alterna Social Responsibility Award from the University of Ottawa.
Chief Financial and Strategy Officer
As Chief Financial and Strategy Officer, Ashley Koch has a proven track record in driving enterprise value creation and operational performance in healthcare. She brings a diverse skill set in partnering with the business to accelerate growth, building infrastructure and processes to drive performance, and developing and actioning insights to execute enterprise-wide strategic initiatives.
Prior to Fullscript, Ashley was CFO of Shields Health Solutions, a PE-backed accelerator and integrator of specialty pharmacies for health systems, and CFO of Steward Medical Group, the largest multi-specialty provider group as part of a national PE-backed integrated health care system. Ashley began her career in financial advisory services and portfolio operations for Cerberus Capital Management.
Chief Product Officer
As Chief Product Officer, Jeff MacDonald leads the growth of Fullscript’s digital products. He oversees Product Management and Product Design, with a focus on aligning Fullscript’s product investments with the company’s vision and strategy.
Jeff brings 10+ years of experience building and leading product teams of all sizes, from large multinationals to technology start-ups. Prior to joining Fullscript, Jeff held product leadership positions at a number of technology companies, including MindBridge AI, You.i TV and IBM.
Chief Operating Officer
As Chief Operating officer, Kevin Purcell is responsible for the day-to-day operations of Fullscript, driving operational improvements across the organization, and leading strategic direction of supply chain US and Canadian footprint.
From May to October of 2022, Kevin played a critical role as Chief Transformation Officer during the integration of Fullscript and Emerson Ecologics post-acquisition. In this role, he partnered with the executive team to identify and realize combined company synergies. Prior to his time at Fullscript, Kevin held the roles of Chief Financial Officer and Chief Operating Officer at Emerson Ecologics.
Dr. Jeff Gladd
Chief Medical Officer
As Chief Medical Officer, Dr. Jeffrey Gladd advises on company and product direction from the perspective of integrative and family medicine. He has been a member of the Fullscript Medical Advisory Team since 2019. In 2010, Dr. Gladd opened GladdMD Integrative Medicine, blending health-promoting care with high access technology. In 2011, he created and launched the web’s first nutrient depletion calculator, Mytavin.com.
With the success of GladdMD, Dr. Gladd has become a sought-after speaker in his field, speaking at TEDx and being featured in various industry publications. Dr. Gladd graduated from medical school in 2001 and after successfully opening a family practice, shifted focus to achieving health through nutrition. In 2009, he completed the University of Arizona Integrative Medicine fellowship program under the direction of Dr. Andrew Weil, MD.
Chief Talent Officer
As Chief Talent Officer, Heather Tyrie leads Fullscript’s Talent and Culture team. She’s responsible for maintaining and evolving the work environment that empowers all Fullscripters to grow personally and professionally. Heather has a diverse background in large and small organizations — both public and private — working in IT, marketing, and human resources.
Her passion is creating rock-solid foundations for companies to grow and thrive. Doing this for the last 20 years has given her a platform to share her expertise, most notably as the first speaker at Ottawa’s inaugural DisruptHR event. Prior to joining Fullscript, Heather worked at a number of technology companies, including You.i TV, iMPath Networks, and Newbridge Networks.
Christy Lynn White
Chief of Staff
Christy joined Fullscript in early 2018 and has served in several key roles during her time with the company. As Chief of Staff, Christy acts as the right hand to the CEO, with a specific focus on further developing and operationalizing Fullscript’s strategic plans, mitigating risk, eliminating silos, and advancing crucial projects across the organization. Prior to joining Fullscript, Christy served in key roles with Nautel Limited and the Government of Canada.
Chief Technology Officer
As Chief Technology Officer, Kurtis Funai manages a team that spreads across eight different technology functions. Kurtis was Fullscript’s fourth employee, leading the product engineering team for many years before serving as VP of Engineering, and now as Chief Technology Officer.
Kurtis built the engine that powers the Fullscript platform. He has been the lead on the development of the company’s primary prescription tool, as well as its powerful refill engine, and has adapted the software to support hospital systems, multi-location clinics, and multi-staff practices. He has also led the development of an API to host integrations with electronic health record (EHR) systems — making Fullscript the first virtual dispensary to do so and setting an industry-standard in the process.
Executive Vice President
Ken joined Fullscript as the former CEO of Emerson Ecologics, with a proven track record of value creation, strategic re-alignment, operational execution, and business transformation. As Executive Vice President, Ken Buttermore leads brand partner strategy and supply chain operations, and is a key member of the teams driving strategic planning and corporate development.
Before his role at Fullscript, and in addition to his role as CEO at Emerson Ecologics, Ken served as Chief Operating Officer, Chief Financial Officer, and SVP of Corporate Development. Concurrent and prior to his time at Emerson, Ken served as Managing Director at Liberty Lane Partners (the owner of Emerson Ecologics) where he executed investments and partnered with operating company management teams in industries such as life sciences, diagnostics, health & wellness, and advanced materials. Ken has also held key roles at Thermo Fisher Scientific Inc. and its predecessor Fisher Scientific International Inc. where he specialized in identifying and executing merger, acquisition, and investment transactions. Early in his career, Ken worked in the investment banking industry.
Bill Conrad’s background is in banking and investments, working as an Investment Banking Analyst in the industrial group of UBS before joining KPS Capital Partners as a Vice President. At KPS, Bill was responsible for identifying, evaluating, and executing control investments across a diverse range of industries.
He has since joined HGGC as an investment partner and member of its Management Committee and Investment Committee. He is involved in all aspects of investment sourcing, underwriting, execution, and portfolio management and realization. He is active in the firm’s Fund IV investments in Aceable, as well as Fund III investments in AMI, Monotype Imaging, Beauty Industry Group, and Better Being.
Managing Partner, Kayne Anderson
Leon Chen is a Managing Partner of Kayne Anderson’s growth capital activities. He is primarily responsible for identifying and analyzing investment opportunities, monitoring of portfolio companies, and deal execution. Chen is a member of Kayne Partners Investment Committee. His areas of investment focus include software and tech-enabled businesses across media and telecom, business services, supply chain and logistics, and healthcare.
Over the years, Chen has developed an investment thesis centered around the use of technology in healthcare to drive greater value for patients and users, improved outcomes, and quality of care in delivery and operations. Leon was recognized as a Leader of Influence in Private Equity by Los Angeles Business Journal and was selected as a Top 25 Healthcare Investor of 2022 by GrowthCap. Chen graduated from the University of Wisconsin, Madison with a B.B.A in Finance.
Snapdragon Capital Partners
Mark Grabowski has over twenty years of private equity experience. He began his career at Merrill Lynch in the Financial Sponsors Group and held roles as an associate at AEA Investors, Managing Director at L Catterton, and Partner at TPG Growth before establishing Snapdragon Capital Partners.
Mark’s prior investments include Corepower Yoga, a leading provider of yoga services, Peloton, the largest provider of at-home fitness, and Angie’s Boomchickapop, a healthy snacking business. Mark attended Dartmouth College for his undergraduate studies and received his MBA from the Wharton School of the University of Pennsylvania.
Ninan Chacko is the Chief Executive Officer at Monotype, one of the largest providers of typography, technology, and expertise to creative professionals. In this role, he oversees a global organization of more than 750 employees, partnering with iconic brands and transforming the adoption and use of digital fonts industry-wide.
Prior to his tenure with Monotype, Chacko served as Senior Advisor to McKinsey, as the Chief Executive Officer for Travel Leaders Group and PR Newswire, and as Chief Commercial Officer for Worldspan. Ninan holds an MSc in Aerospace Engineering from the University of Kansas. He has also completed Harvard Business School’s Advanced Management Program and the London Business School’s Spencer Stuart Directors’ Forum.
Partner, Novalis LifeSciences
Paul is a partner at Novalis LifeSciences, a life-sciences venture fund and co-founder of Liberty Lane Partners, a private investment company. He serves as Chairman of Arbor Biotechnologies and Amneal Pharmaceuticals and is on the board of Aptiv PLC, Quanterix, Ori Biotech, Sherlock Biosciences and several other early-stage life science tools and diagnostic companies.
Previously Paul served as Chairman of Thermo Fisher Scientific and Vice Chairman of Fisher Scientific International. He also served as Chairman and CEO of inVentiv Health (now Syneos Heath), and president of MacAndrews and Forbes. Paul earned a MBA from Northwestern University and a BA from the University of Michigan and serves on the board of Michigan’s Life Sciences Institute, and the Provost’s Advisory Council.
Head of Data and
Founding Partner, Backbone
Solmaz Shahalizadeh is an executive and advisor in data and product, and a founding partner of Backbone Angels, a collective focused on funding more diverse and women-founded companies. Most recently, she was the Vice President and head of Data at Shopify (NYSE: SHOP), helping it grow from 100K to 1.75M+ merchants from 2013 to 2022. In her role, Solmaz was the senior leadership team’s voice of data, evangelized a data-informed culture across the company, and played a critical role in their successful IPO in 2015.
With a passion for data-powered experiences, she started and scaled Shopify’s machine learning product portfolio and grew its data team to 500+ data scientists, engineers, and product managers. Additionally, she led the suite of merchant-facing analytical products to give Shopify merchants best-in-class analytical experiences. Solmaz is passionate about entrepreneurs and data, spending her time coaching, advising, and investing in companies that want to leverage their data for better experiences.
Solmaz won the Globe and Mail’s 2020 Report on Business Best Executive award and the Ottawa Business Journal’s 2021 Forty Under 40, both recognizing her leadership and work in Technology.
Aimee Miller is a strategic Go-to-market advisor with significant expertise in all areas of marketing strategy and execution. Aimee most recently served as the CMO (2009-2022) of AppFolio (NASDAQ:APPF) a leading provider of cloud-based solutions for the real estate industry, where she built and led all aspects of marketing and corporate communications from company launch, through a successful IPO (2015) and during years of rapid growth. She was instrumental in creating an award-winning culture and brand, and during her tenure at AppFolio the company grew to $450M in revenue and over 18K customers.
Prior to AppFolio, Aimee led Strategic Accounts and B2B Marketing at Citrix Online (acquired by LogMein, now GoTo), where she was involved in the launch and marketing of some of their earliest SasS offerings. Aimee currently serves on the board of the Scholarship Foundation of Santa Barbara, the largest community-based provider of college scholarships in the United States.